Cancer Therapy Shows Promise for Autoimmune Diseases

Imagine treating a lifelong disease with just one therapy instead of daily medications forever. That's the promise researchers are seeing with a cancer treatment now being tested on autoimmune diseases.

About 8 percent of Americans live with autoimmune diseases, conditions where the immune system attacks healthy cells and organs. Between 80 and 150 different autoimmune diseases exist, from lupus to multiple sclerosis, and most require daily pills or injections that suppress the immune system and come with challenging side effects.

Dr. Alicia Lieberman at Roswell Park Comprehensive Cancer Center in Buffalo, New York, is leading research into whether CAR T-cell therapy could change that. The therapy genetically engineers a patient's own immune cells to fight disease, and it's already revolutionized cancer treatment.

Now, early clinical trials are showing it might do the same for autoimmune conditions. Patients with severe lupus, scleroderma, MS, and other neurologic conditions who received the treatment have experienced significant symptom improvement, and some have seen complete reversal.

The key difference from current treatments is the potential for lasting change. While traditional therapies dampen the immune response temporarily, CAR T-cell therapy aims to reset it entirely. The engineered cells work to disrupt the autoimmune process in the tissue itself.

"This would be an immune reset," Lieberman explained. "The hope is that people will not need treatments long-term." Instead of managing symptoms daily for decades, patients might receive one treatment that trains their body to fight back against the disease.

The research team is currently enrolling patients with severe autoimmune diseases. Their next phase will study how long the immune reset lasts and measure its effectiveness across different conditions.

The Bright Side

For the millions managing autoimmune diseases with multiple daily medications, this research represents more than just symptom relief. It's the possibility of freedom from constant pills, injections, and the side effects that come with suppressing your immune system. These early results are opening doors that seemed permanently closed for conditions long considered incurable.

Clinical trials are accepting new participants now, offering hope that what works against cancer might soon work against the body's own misdirected defenses.